Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

CT scans can find serious prostate cancer even when PSA levels are low.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

CEC levels may be a useful marker for predicting prostate cancer progression.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.